Rockford woman is 1st in Wisconsin to receive newly-approved FDA ALS treatment
![](/images/cbslogo_gray.png?x)
-
2:06
Light snow and freezing drizzle likely Wednesday evening
-
4:57
An inside look at the DEA’s North Central Lab
-
2:28
Educators brace for uncertain future as Trump administration...
-
3:07
Former air traffic controller at MKE shares insight into D.C....
-
1:42
FDA-approved blood test detecting colon cancer hopes to increase...
-
1:00
Burlington police ID victim of fatal Menards parking lot crash
-
1:58
Police arrest person of interest after man found dead in Kenosha...
-
2:08
Amber Alert issued for pregnant teen missing out of Beaver Dam
-
2:19
’It’s unbelievable, we would never expect this’: Waukesha...
-
1:51
GOP immigration bill would require Milwaukee to help ICE or lose...
-
2:14
Arrowhead Union High School District could change inclusive language...
-
4:24
UW Health officer discusses heart disease, new FDA-approved painkiller
ROCKFORD, Ill. (CBS 58) -- A Rockford, Illinois woman is the first in Wisconsin to receive a new FDA-approved treatment for ALS, or Lou Gehrig's disease.
Michelle Francis was first diagnosed in 2019 with what's called the SOD1 mutation.
The disease has run in her family for seven generations, affecting 65 members and counting.
In April, UW Health in Madison offered a glimmer of hope -- a monthly treatment involved removing spinal fluid with a needle and replacing it with a new drug.
Now, nearly eight appointments later, Francis says she has hope for the first time.
"It will be here forever so we definitely have to have something to once you develop, there's some hope and I’m thinking this is gonna be it," said Francis.
Francis says she hopes others with ALS will hear her story, be inspired, and most importantly, not give up.